Publication date: 14 December 2015
Source:Cancer Cell, Volume 28, Issue 6
Author(s): Nathan R. West, Fiona Powrie
Gut microbes have ascended to prominence as key modulators of host immunity, raising the possibility that they could influence the outcome of cancer immunotherapy. Two recent studies address this question by identifying specific gut-resident bacteria as drivers of checkpoint blockade immunotherapy in pre-clinical tumor models.
Teaser
Gut microbes have ascended to prominence as key modulators of host immunity, raising the possibility that they could influence the outcome of cancer immunotherapy. Two recent studies address this question by identifying specific gut-resident bacteria as drivers of checkpoint blockade immunotherapy in pre-clinical tumor models.from Cancer via ola Kala on Inoreader http://ift.tt/1lLWQPS
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου